Unknown PHASE4 INTERVENTIONAL 1-arm NCT00658931

Cymbalta for Depression as a Complication of Bereavement

Sponsor: Eli Lilly and Company

Interventions Drug treatment with Cymbalta

Updated 6 times since 2017 Last updated: Feb 10, 2010 Started: Apr 30, 2008 Primary completion: Apr 30, 2010 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00658931, this PHASE4 trial focuses on Bereavement and Depression and remains ongoing. Sponsored by Eli Lilly and Company, it has been updated 6 times since 2008, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eli Lilly and Company
Jefferson Clinic, P.C.

Data source: Jefferson Clinic, P.C.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United States